| Identification | More | [Name]
5-Methylsalicylaldehyde | [CAS]
613-84-3 | [Synonyms]
2,5-CRESOTALDEHYDE
2-HYDROXY-5-METHYLBENZALDEHYDE
2-HYDROXY-5-METHYLSALICYLALDEHYDE
5-METHYLSALICYLALDEHYDE
ASISCHEM D29246
2-hydroxy-5-methyl-benzaldehyd
2-Hydroxy-5-Methylbenzaldehyde (5-Methoxysalicylaldehyde)
Benzaldehyde, 2-hydroxy-5-methyl-
5-METHYLSALICYLALDEHYDE 97+%
2,5-Cresotaldehyde, 5-Methylsalicylaldehyde
2-Formyl-4-methylphenol
5-Methyl-2-hydroxybenzaldehyde
NSC 97517 | [EINECS(EC#)]
210-357-6 | [Molecular Formula]
C8H8O2 | [MDL Number]
MFCD00274297 | [Molecular Weight]
136.15 | [MOL File]
613-84-3.mol |
| Chemical Properties | Back Directory | [Appearance]
Pale yellow to yellow crystalline powder | [Melting point ]
54-57 °C(lit.)
| [Boiling point ]
217 °C(lit.)
| [density ]
1.0913 | [refractive index ]
1.5470 (estimate) | [storage temp. ]
Keep in dark place,Sealed in dry,Room Temperature | [solubility ]
soluble in Methanol | [form ]
Crystalline Powder | [pka]
8.47±0.18(Predicted) | [color ]
Pale yellow to yellow | [BRN ]
2040673 | [InChI]
1S/C8H8O2/c1-6-2-3-8(10)7(4-6)5-9/h2-5,10H,1H3 | [InChIKey]
ILEIUTCVWLYZOM-UHFFFAOYSA-N | [SMILES]
Cc1ccc(O)c(C=O)c1 | [CAS DataBase Reference]
613-84-3(CAS DataBase Reference) | [NIST Chemistry Reference]
2-Hydroxy-5-methylbenzaldehyde(613-84-3) | [EPA Substance Registry System]
613-84-3(EPA Substance) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing . | [WGK Germany ]
3
| [Hazard Note ]
Irritant | [TSCA ]
TSCA listed | [HS Code ]
29124990 | [Storage Class]
11 - Combustible Solids | [Hazard Classifications]
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3 |
| Hazard Information | Back Directory | [Chemical Properties]
Pale yellow to yellow crystalline powder | [Uses]
2-Hydroxy-5-methylbenzaldehyde is used in preparation of novel 2-Phenylcyclopropanamine derivatives as Lysine-specific Demethylase 1 inhibitors (LSD1-inhibitors) for prevention or treatment of primary brain tumor. |
|
|